Bacillus Calmette-Guerin (BCG) vaccine in Iran
- PMID: 31720387
- PMCID: PMC6830148
- DOI: 10.1016/j.jctube.2018.02.001
Bacillus Calmette-Guerin (BCG) vaccine in Iran
Erratum in
-
Erratum regarding previously published articles.J Clin Tuberc Other Mycobact Dis. 2020 Sep 9;21:100177. doi: 10.1016/j.jctube.2020.100177. eCollection 2020 Dec. J Clin Tuberc Other Mycobact Dis. 2020. PMID: 32964144 Free PMC article.
Keywords: Bacillus Calmette-Guerin; Tuberculosis.
References
-
- Fallah F, Karimi A, Abdolghafoorian H, Mohammadzadeh A, Zahraei S, Goudarzi H. Molecular analysis of the bacille Calmette-Guérin vaccine strain currently being used in Iran. Int J Tuberculosis Lung Dis. 2016;20(2):223–227. - PubMed
-
- Shojaei H, Rahimi-Hajiabadi H, Heidarieh P, Hashemi-Shahraki A, Emadoleslami M, Ataei B. Molecular microbiological investigation of post-vaccination bacille Calmette-Guérin infection in Iranian patients. Int J Tuberculosis Lung Dis. 2011;15(11):1497–1504. - PubMed
-
- Shahi F, Fallah F, Goudarzi H, Baniasad M, Pourabbas B, Mohammadzade A. Molecular characterization of mycobacterium strains isolated from children with BCG induced lymphadenitis. Res Med. 2015;39(1):30–35.
-
- Deeks SL, Clark M, Scheifele DW, Law BJ, Dawar M, Ahmadipour N. Serious adverse events associated with bacille Calmette-Guerin vaccine in Canada. Pediatr Infect Dis J. 2005;24(6):538–541. - PubMed
LinkOut - more resources
Full Text Sources
